Opterion: a disruptive dialysis treatment
Opterion Health AG, based in Muttenz, Switzerland, is developing a highly disruptive dialysis / end stage kidney disease treatment likely...
Safe harbor
iolite does not engage in general solicitation. Investments may only be made by financially sophisticated individuals who have a pre-existing relationship with iolite and meet certain investment standards. No securities are available for sale through this website and nothing on this website shall constitute an offer or a solicitation for the sale of any security.